Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,434,873 papers from all fields of science
Search
Sign In
Create Free Account
aaptamine
Known as:
8,9-dimethoxy-1H-benzo(de)(1,6)naphthyridine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
2-methoxy-3-oxoaaptamine
Broader (1)
Naphthyridines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Aaptos sp. merupakan spons laut yang dapat memproduksi senyawa bioaktif seperti aaptamin, aaptosin, dan isoaaptamin yang memiliki aktivitas sebagai antitumor, antimikrobial, dan antiviral. Komunitas…
Ekowati Chasanah
,
Gintung Patantis
,
A. S. Dewi
,
Hedi Indra Januar
,
Susan Soka
2013
Corpus ID: 54826320
*Corresponding author; Phone: 62-21-53650157, Fax: +6221-53650158, Email: ekowatichasanah@gmail.com Aaptos sp., one of marine…
Expand
2008
2008
Novel alkaloids of the aaptamine class from an Indonesian marine sponge Aapto Aaptos
I. W. Mudianta
,
M. Garson
2008
Corpus ID: 82983567
2006
2006
Screening and Isolation of Cytotoxic Compounds From Local Marine Aaptos Species
Cheng Ling Kee
2006
Corpus ID: 55279894
Over the recent years, marine sponges have been the target of research as a source of new chemicals with therapeutic potential…
Expand
2005
2005
P-7 Aaptamine, a spongean alkaloid, activates p21 promoter
S. Aoki
,
Dexin Kong
,
Motomasa Kobayashi
,
Y. Sowa
,
T. Sakai
2005
Corpus ID: 87846540
1990
1990
Aaptamine-new selective inhibitor of type a monoamine oxidases
D. I. Ioffina
,
O. É. Volkovitskaya
,
V. Gorkin
,
N. M. Rebachuk
,
N. Utkina
,
S. A. Fedoreev
Pharmaceutical Chemistry Journal
1990
Corpus ID: 13183109
The search for new monoamine oxidase (MAO) inhibitors, which selectively block the activity of MAO of types A or B, seems to be…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE